Home > Insider Trading > Filing (0000899243-21-031149)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1786255	Icosavax Inc.	ICVX	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1242126	Mark Mcdade	11100 Ne 8Th St Suite 200 Bellevue WA 98004	No	No	No	Yes
1765710	Qiming U.s. Healthcare Fund Ii, L.p.	11100 Ne 8Th St. Suite 200 Bellevue WA 98004	No	No	No	Yes
1868862	Qiming U.s. Healthcare Gp Ii, Llc	11100 Ne 8Th St Suite 200 Bellevue WA 98004	No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-08-02	3,310,228	$0.00	3,310,228	No	4	C	Direct
Common Stock	Acquisiton	2021-08-02	200,000	$15.00	3,510,228	No	4	P	Direct
Common Stock	Acquisiton	2021-08-02	8,018	$15.00	3,518,246	No	4	P	Direct
Common Stock	Acquisiton	2021-08-02	13,333	$15.00	3,523,561	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 Preferred Stock	Disposition	2021-08-02	12,480,498	$0.00	3,003,224	$0.00
Common Stock	Series B-1 Preferred Stock	Disposition	2021-08-02	1,275,817	$0.00	307,004	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

On August 2, 2021, the shares of Series A-1 Preferred Stock and Series B-1 Preferred Stock converted into shares of the Issuer's common stock at a ratio of 4.1557-for-1 automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date. As a result of the Issuer's initial public offering, Qiming U.S. Healthcare Fund II, L.P. ("Qiming") is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer.
The securities are directly held by Qiming. Qiming U.S. Healthcare GP II, LLC ("Qiming GP") is the General Partner of Qiming. Gary Rieschel and Mark McDade are the managing members of Qiming GP. As a result, each of Qiming GP and Messrs. Rieschel and McDade may be deemed to beneficially own the shares held by Qiming.
Shares reported herein as purchased on August 2, 2021 represent 8,018 shares of Common Stock purchased by Mark McDade.
Shares reported herein as purchased on August 2, 2021 represent 13,333 shares of Common Stock purchased by Gary Rieschel.
Shares reported herein as purchased on August 2, 2021 represent 200,000 shares of Common Stock purchased by Qiming.